Hotspot TCR-T therapy

TCR-engineered T cells targeting hotspot epitopes · Providence Health & Services

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hotspot TCR-T therapy, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T) [Phase 1]

See pricing